Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138749
Status:
COMPLETED
Last Update Posted:
2011-04-07
First Post:
2005-08-26
Brief Title:
An 8 Week Study Looking At The Efficacy Toleration And Safety Of SS-RBX For Stress Urinary Incontinence
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An 8-Week Multi-CentreRandomised Double-Blind Placebo Controlled Parallel Group Study To Evaluate The EfficacyToleration And Safety Of - SS- Reboxetine In The Treatment Of Stress Urinary Incontinence SUI In Women
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study designed to assess the efficacy toleration and safety of SS-RBX for the treatment of stress urinary incontinence
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None